The short answer
The Advanced Research Projects Agency for Health funds high-risk, high-reward health research that traditional funders and companies are unlikely to take on. It runs cancer-focused programs aimed at early detection, adaptive treatment, and radiotherapy. It funds projects, so it is not a place a patient goes for care.
ARPA-H's stated mission is to support high-impact solutions to society's most challenging health problems, delivering health breakthroughs in years, not decades.
It funds high-potential, high-impact research that cannot be readily accomplished through traditional research or commercial activity.
It sits within the Department of Health and Human Services and follows HHS policies.
Program Managers serve limited terms to keep a constant infusion of fresh thinking and new perspectives.
Choose how you want to understand this
The full explanation.
An agency built for long shots
Most health research funding rewards careful, incremental work. A researcher proposes a study, reviewers judge whether it is likely to succeed, and the safe bets tend to win.
ARPA-H was built to do the opposite. Its stated mission is to support the development of high-impact solutions to society's most challenging health problems, delivering health breakthroughs in years, not decades.
It looks specifically for high-potential, high-impact biomedical and health research that cannot be readily accomplished through traditional research or commercial activity. That phrase is the whole design. If a university lab or a company would do it anyway, it is not an ARPA-H project.
The agency sits inside the Department of Health and Human Services and follows HHS policies, and it reports to Congress and the White House.
How it runs
The engine of ARPA-H is the Program Manager. These are people brought in to design and drive a specific program, and they serve for limited terms so that there is a constant infusion of fresh thinking and new perspectives.
The agency describes its method as rigorous program design, a competitive project selection process, and active program management. That last part matters. Programs are steered, not just funded and forgotten.
And ARPA-H says something out loud that most funders will not. It embraces productive failure as the price of transformative success.
That is an unusual thing for a government agency to put in writing. It is also the honest cost of aiming at things that might not be possible yet.
The cancer programs
ARPA-H names its programs as questions, which makes them easy to understand.
1 Cure asks what if we could develop radiotherapy technology to enable one low-cost curative treatment effective for all cancers.
ADAPT asks what if we could adapt cancer treatments as tumours mutate and change.
POSEIDON asks what if a simple test could save millions of lives by catching cancer early.
Read those again and notice how large they are. Each one targets a limitation that patients and oncologists live with every day. Treatment that stops working as a tumour evolves. Cancers found too late. Radiotherapy that is expensive and unevenly available.
Whether any of them succeeds is genuinely unknown. That is the point of the agency.
What ARPA-H can do for you today
It can tell you that serious money and serious attention are pointed at the exact problems that make cancer hard. Not vaguely, but in named programs with stated goals. For some people, that is worth knowing.
It can help you understand the shape of the research world. When you read that a new detection test or an adaptive treatment approach is being developed, ARPA-H is one of the places that kind of work gets started, well before any of it reaches a clinic.
It can also give you better questions for your own team. If early detection or treatment resistance is what worries you most about your situation, that is a conversation worth having with the people managing your care.
What ARPA-H cannot do for you
It cannot treat you. ARPA-H funds programs. It does not run clinics, see patients, or provide care to individuals.
It cannot enroll you in anything. Its programs are research efforts, not recruiting studies. If a program eventually produces something testable, trials would be run by universities, hospitals, or companies, and listed through the usual trial channels.
It cannot promise a timeline. "Years, not decades" is a target for the agency's way of working, not a delivery date for any particular program.
It cannot promise success at all, and says so. Productive failure is part of the model.
And it gives no medical advice. Nothing on an ARPA-H page should change what you and your oncologist decide this month.
Holding hope and treatment separately
There is a trap here worth naming gently.
When treatment is hard, news of a bold research program can start to feel like an option. It is tempting to think about holding on until something arrives.
Research does not work that way, and ARPA-H is unusually clear about the odds. The programs are worth knowing about because they show the problems are being taken seriously, not because they offer a plan for this year.
The decisions in front of you now, about standard treatment and about trials that are actually recruiting, are the ones that affect your outcome. Ask your team what is open to you today. Program details and lists on the ARPA-H site change as work starts and ends, so check the current version there rather than relying on a description you read once.
Hope in the long project is reasonable. Just do not let it stand in for the conversation you can have this week.
Words to know
Tap any term to see what it means.
Common questions
Can I get treatment through ARPA-H?
No. ARPA-H funds research programs. It does not run a clinic and does not provide care to individuals.
Are ARPA-H programs the same as clinical trials I can join?
Not directly. A funded program may eventually lead to trials run by universities or companies. Trials that are actually recruiting are listed through other channels, and your care team is the place to start.
How is ARPA-H different from the NIH or NCI?
ARPA-H is set up for research that cannot be readily accomplished through traditional research or commercial activity, using time-limited Program Managers and active program management. It is a different funding model, inside the same department.
What does "productive failure" mean?
ARPA-H says it accepts productive failure as the price of transformative success. Some ambitious projects are expected not to work, and that is built into the model.
What are 1 Cure, ADAPT and POSEIDON?
They are named ARPA-H programs. 1 Cure asks whether radiotherapy technology could enable one low-cost curative treatment effective for all cancers. ADAPT asks whether treatments could adapt as tumours mutate and change. POSEIDON asks whether a simple test could catch cancer early.
Should I wait for an ARPA-H breakthrough?
No. Research timelines are uncertain even when a program succeeds. Decisions about your treatment belong with your medical team now.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Your next step
Turn this topic into questions for your next appointment.
Speak With Trained Specialists & Human Navigators
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.
Sources last checked: 2026-09-03 what this meansLast updated: 2026-09-03Next planned review: 2027-09-03
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes, and this is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status — Editorial review complete. This page completed Cancer Explained's editorial checks (sources, safety, plain language, duplication). It has not been reviewed by a physician or other healthcare professional.
General education. Low-risk educational or organizational content. Medical facts are cited to authoritative sources.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes, and this is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Editorial review complete — This page completed Cancer Explained's editorial checks (sources, safety, plain language, duplication). It has not been reviewed by a physician or other healthcare professional.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.
Related articles
Still have questions?
Educational answers, plain language
Free to print and share